Reply: Pretreatment with Unfractionated Heparin in Patients Undergoing Primary PCI: a Standard of Treatment Together with DAPT?
Overview
Overview
Journal
EuroIntervention
Specialties
Cardiology & Vascular Diseases
Pharmacology
Pharmacology
Date
2023 Apr 24
PMID
37092267
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Montalescot G, van t Hof A, Lapostolle F, Silvain J, Lassen J, Bolognese L
. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014; 371(11):1016-27.
DOI: 10.1056/NEJMoa1407024.
View
2.
Fabris E, van t Hof A
. Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?. EuroIntervention. 2023; 18(17):1471-1472.
DOI: 10.4244/EIJ-D-22-00821.
View
3.
Tavenier A, Hermanides R, Fabris E, Angiolillo D, van t Hof A
. Bridging the gap: Current and future insights for improving suboptimal platelet inhibition in STEMI. Int J Cardiol. 2020; 328:40-45.
DOI: 10.1016/j.ijcard.2020.11.042.
View
4.
Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay J
. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013; 369(11):999-1010.
DOI: 10.1056/NEJMoa1308075.
View
5.
Emilsson O, Bergman S, Mohammad M, Olivecrona G, Gotberg M, Erlinge D
. Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). EuroIntervention. 2022; 18(9):709-718.
PMC: 10241276.
DOI: 10.4244/EIJ-D-22-00432.
View